- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00947648
Outpatient Neutropenic Diet Study
Are Neutropenic Diets Beneficial to Improve Outcome?
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study is comparing two different diets. The cooked group will be allowed to eat only cooked food and cooked fruits or vegetables. The raw group will be able to eat cooked food and the addition of fresh fruits and vegetables. Patients will be monitored for infection in both groups. There are still certain foods that you are restricted from eating while receiving chemotherapy and you will be given a list of these restrictions.
Study Groups:
If you agree to take part in this study, you will be randomly assigned (as in the flip of a coin) to 1 of 2 groups.
Group 1: Raw group: You will be asked to eat at least 1 raw fruit or vegetable every day you are on study.
Group 2: Cooked group: You will eat only cooked foods while on study. The study doctor will give you a list of the foods that you are allowed to eat.
Your medical chart will be monitored while you are on study to check how often you need antibiotics to treat fever. or if you have an infection.
Diet Questionnaire:
You will be asked to fill out a diet questionnaire every week. The questionnaire will have 5 questions about the foods you have been eating. If you have been released from the hospital, you can return the questionnaire during your scheduled hospital visits,which typically take place 3 times per week. You will have no additional visits during this study. The questionnaire should take about 1-2 minutes each time.
Length of Study:
You will be taken off study if your white blood cell count returns to normal. If your white blood cell counts do not return to normal, the maximum time that you may be on study is 6 weeks.
This is an investigational study. There has not been enough research to prove if raw fruits and vegetables can increase your risk of infection. Many hospitals allow neutropenic patients to eat raw fruits and vegetables and other hospitals restrict fresh fruits and vegetables but, this has not been adequately investigated.
Up to 128 patients will take part in this study. All will be enrolled at M. D. Anderson.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- U.T. M.D. Anderson Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Newly diagnosed patients with acute myelogenous leukemia (AML), acute lymphocytic leukemia ( ALL), or myelodysplastic syndrome (MDS) receiving induction chemotherapy or AML, ALL or MDS patients who are in remission receiving consolidation chemotherapy.
- Patients who will be receiving myelosuppressive chemotherapy for their disease.
- Patients who will be able to stay in the Houston area for at least 4 weeks.
- Patients who can speak either English or Spanish.
Exclusion Criteria:
- Patients who present with an active infection such as pneumonia, bacteremia, urine, c. difficile or cellulitis infection.
- Patients who are unable to understand the diet questionnaire which will be written in either English or Spanish.
- Patients who are admitted to the protective environment.
- Patients who are younger than age 18 will not be entered in the study.
- Pregnant patients.
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: "Raw" Group
Participants will eat cooked food and the addition of raw fruits and vegetables.
|
Diet containing fresh fruits and vegetables in addition to cooked food.
|
Other: "Cooked" Group
Participants will eat only cooked foods.
|
Diet containing only cooked foods.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Bactermia in Each Participant Group
Time Frame: 6 weeks
|
Participants evaluated for presence of bacteremia (gram positive, gram negative, and or candidemia).
Participants also evaluated for neutropenic fever requiring administration of antibiotics even if the participant does not have a positive blood culture on a weekly basis.
At least 2 positive blood cultures are needed for coagulase-negative staphylococci (CoNS) to be considered bacteremia.
|
6 weeks
|
Infection Rate
Time Frame: 6 weeks
|
Episodes of neutropenic fevers requiring IV antibiotics and or hospitalization because many times patients have an infection but there is no positive blood cultures.
Evaluation of bacteremia will be done by the two nurse investigators via a data questionnaire weekly, see Appendix E. Patients will require at least 2 positive blood cultures for coag neg staph to be considered bacteremia and if there are any other questionable organisms that could be a contaminant, an infectious disease expert is one of the co-investigators and this person will be consulted if this positive blood culture is considered an infection.
If the patient has a fever requiring antibiotics with this positive blood culture, then this will also be considered as to whether this is a true infection.
|
6 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Alison E Gardner, PhD, M.D. Anderson Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2008-0369
- NCI-2009-01509 (Registry Identifier: NCI CTRP)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Leukemia
-
Stanford UniversityTerminatedLeukemia | Leukemia, Lymphocytic, Acute | Leukemia Acute Promyelocytic Leukemia (APL) | Leukemia Acute Lymphoid Leukemia (ALL) | Leukemia Chronic Myelogenous Leukemia (CML) | Leukemia Acute Myeloid Leukemia (AML) | Leukemia Chronic Lymphocytic Leukemia (CLL)United States
-
Massachusetts General HospitalCelgene CorporationTerminatedAcute Myelogenous Leukemia | Acute Myeloid Leukemia (AML) | Acute Myelocytic Leukemia | Acute Granulocytic Leukemia | Acute Non-Lymphocytic LeukemiaUnited States
-
Institute of Hematology & Blood Diseases HospitalBejing Institute for Stem Cell and Regenerative Medicine; Institute for Stem...RecruitingRefractory Leukemia | Relapsed Leukemia | Acute Myeloid Leukemia, ChildhoodChina
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Monoblastic Leukemia (M5a) | Childhood Acute Monocytic Leukemia (M5b) | Childhood Acute Myeloblastic Leukemia Without Maturation (M1) | Childhood Acute Myelomonocytic Leukemia (M4) | Childhood Acute Myeloid Leukemia/Other Myeloid MalignanciesUnited States
-
Hybrigenics CorporationUnknownAcute Myelogenous LeukemiaUnited States, France
-
Betta Pharmaceuticals Co., Ltd.Not yet recruitingAcute Myeloid Leukemia LeukemiaChina
-
Beijing Boren HospitalRecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapse LeukemiaChina
-
Center for International Blood and Marrow Transplant...National Marrow Donor Program; St. Baldrick's FoundationActive, not recruitingAcute Myelogenous LeukemiaUnited States
-
Massachusetts General HospitalCompleted
-
Kinex Pharmaceuticals Inc.CompletedAcute Myelogenous LeukemiaUnited States
Clinical Trials on Raw Fruits & Vegetables
-
Baylor Research InstituteCompletedCardiovascular Diseases | Hypertension | Chronic Kidney DiseasesUnited States
-
The University of Tennessee, KnoxvilleActive, not recruitingObesityUnited States
-
Laval UniversityCompleted
-
Baylor Research InstituteCompleted
-
University of California, San FranciscoAmerican Heart AssociationNot yet recruiting
-
United Arab Emirates UniversityUnknownVisceral ObesityUnited Arab Emirates
-
University of ManitobaDalhousie UniversityRecruitingChronic Kidney Disease | HyperkalemiaCanada
-
University of Nebraska LincolnCompletedObesity | OverweightUnited States
-
Texas Tech University Health Sciences CenterCompletedHealth BehaviorUnited States
-
University of NebraskaCompleted